Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
about
New York Heart Association class and the survival benefit from primary prevention implantable cardioverter defibrillators: A pooled analysis of 4 randomized controlled trials.Clinical Trial Design, Endpoints, and Regulatory Requirements.Frailty as a Risk Factor for Cardiovascular Versus Noncardiovascular Mortality in Older Men: Results From the MrOS Sleep (Outcomes of Sleep Disorders in Older Men) Study.
P2860
Use of the 6-min walk distance to identify variations in treatment benefits from implantable cardioverter-defibrillator and amiodarone: results from the SCD-HeFT (Sudden Cardiac Death in Heart Failure Trial).
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Use of the 6-min walk distance ...... Death in Heart Failure Trial).
@en
Use of the 6-min walk distance ...... one: results from the SCD-HeFT
@nl
type
label
Use of the 6-min walk distance ...... Death in Heart Failure Trial).
@en
Use of the 6-min walk distance ...... one: results from the SCD-HeFT
@nl
prefLabel
Use of the 6-min walk distance ...... Death in Heart Failure Trial).
@en
Use of the 6-min walk distance ...... one: results from the SCD-HeFT
@nl
P2093
P50
P1476
Use of the 6-min walk distance ...... Death in Heart Failure Trial).
@en
P2093
Daniel P Fishbein
George Johnson
Mary Norine Walsh
SCD-HeFT Investigators
P304
P356
10.1016/J.JACC.2014.02.602
P407
P577
2014-04-09T00:00:00Z